BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 2974279)

  • 1. Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin.
    Rijken DC; Groeneveld E; Kluft C; Nieuwenhuis HK
    Biochem J; 1988 Oct; 255(2):609-15. PubMed ID: 2974279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
    Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
    J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of the inhibition of plasmin in acidified human plasma.
    Lijnen HR; Maes M; Castel M; Samama M; Collen D
    Thromb Haemost; 1982 Dec; 48(3):257-9. PubMed ID: 6219470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activity.
    Holmes WE; Lijnen HR; Nelles L; Kluft C; Nieuwenhuis HK; Rijken DC; Collen D
    Science; 1987 Oct; 238(4824):209-11. PubMed ID: 2958938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of plasmin with tranexamic acid and alpha 2 plasmin inhibitor in the plasma and clot.
    Takada A; Ito T; Takada Y
    Thromb Haemost; 1980 Feb; 43(1):20-3. PubMed ID: 6447383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/alpha 2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin.
    Kramer MD; Reinartz J
    J Clin Invest; 1993 Aug; 92(2):978-83. PubMed ID: 7688770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between staphylokinase, plasmin(ogen), and alpha 2-antiplasmin. Recycling of staphylokinase after neutralization of the plasmin-staphylokinase complex by alpha 2-antiplasmin.
    Silence K; Collen D; Lijnen HR
    J Biol Chem; 1993 May; 268(13):9811-6. PubMed ID: 7683664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the antiplasmin activity of human thrombospondin-1 in solution.
    Anonick PK; Yoo JK; Webb DJ; Gonias SL
    Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):903-9. PubMed ID: 7679575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of plasmin inhibition in the presence of a synthetic tripeptide substrate. The reaction with pancreatic trypsin inhibitor and two forms of alpha 2-plasmin inhibitor.
    Petersen LC; Clemmensen I
    Biochem J; 1981 Oct; 199(1):121-7. PubMed ID: 6175313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatocyte receptors for proteinase inhibitor complexes with plasmin].
    Zorin NA; Zhabin SG; Gorin VS
    Tsitologiia; 1993; 35(2):55-9. PubMed ID: 7686697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of human alpha 2-antiplasmin with chicken IgY specific to its carboxy-terminal peptide.
    Lee SC; Lee KN; Schwartzott DG; Jackson KW; Tae WC; McKee PA
    Prep Biochem Biotechnol; 1997 Nov; 27(4):227-37. PubMed ID: 9413556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
    Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
    Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
    Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
    Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the serpin alpha(2)-antiplasmin by stromelysin-1.
    Lijnen HR; Van Hoef B; Collen D
    Biochim Biophys Acta; 2001 Jun; 1547(2):206-13. PubMed ID: 11410276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence in bovine milk of two protease inhibitors of the plasmin system.
    Precetti AS; Oria MP; Nielsen SS
    J Dairy Sci; 1997 Aug; 80(8):1490-6. PubMed ID: 9276788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unique pathway for the plasma elimination of alpha 2-antiplasmin-protease complexes in mice.
    Gonias SL; Fuchs HE; Pizzo SV
    Thromb Haemost; 1982 Oct; 48(2):208-10. PubMed ID: 6758181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and secretion of the fibrinolytic components, including alpha 2-antiplasmin, by a human hepatoma cell line.
    Fair DS; Plow EF
    J Lab Clin Med; 1983 Mar; 101(3):372-84. PubMed ID: 6186756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reaction of human alpha2-antiplasmin and plasmin stopped-flow fluorescence kinetics.
    Christensen U; Bangert K; Thorsen S
    FEBS Lett; 1996 May; 387(1):58-62. PubMed ID: 8654567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of plasmin activity by aspirin.
    Milwidsky A; Finci-Yeheskel Z; Mayer M
    Thromb Haemost; 1991 Apr; 65(4):389-93. PubMed ID: 1829277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of conserved lysine residues in the alpha2-antiplasmin C terminus to plasmin binding and inhibition.
    Lu BG; Sofian T; Law RH; Coughlin PB; Horvath AJ
    J Biol Chem; 2011 Jul; 286(28):24544-52. PubMed ID: 21543325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.